| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9154515 | American Heart Journal | 2005 | 10 Pages |
Abstract
The results of the present study demonstrate that (a) adding valsartan to prescribed therapy for HF significantly reduces the incidence of AF by 37%; (b) BNP level and advanced age were the strongest independent predictors for AF occurrence; and (c) AF occurrence further worsens the outcome in patients with HF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Aldo P. MD, Roberto MD, Peter E. MD, Steven N. MD, Simona MS, Robert MD, Serge MD, Elisabetta MD, Gianni MD, Jay N. MD, for the Val-HeFT Investigators for the Val-HeFT Investigators,